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Procyanidins, the main ingredient of apple polyphenols, are known to possess 20 
anti-oxidative and anti-inflammatory effects associated closely with the 21 
pathophysiology of insulin resistance and type 2 diabetes. We investigated the effects 22 
of orally administered apple procyanidins (APCs) on glucose metabolism using 23 
diabetic ob/ob mice. We found no difference in body weight or body composition 24 
between APCs-treated and untreated mice. 4-week oral administration of APCs 25 
containing water (0.5% w/v) ameliorated glucose tolerance, insulin resistance, and 26 
hepatic gluconeogenesis in ob/ob mice. APCs also suppressed the increase of 27 
pancreatic β-cell. Insulin-stimulated Akt phosphorylation was significantly enhanced, 28 
pro-inflammatory cytokine expression levels were significantly decreased, and c-Jun 29 
N-terminal kinase (JNK) phosphorylation was down-regulated in the liver of those 30 
APCs-treated mice. In conclusion, APCs ameliorate insulin resistance by improving 31 
hepatic insulin signaling through suppression of hepatic inflammation in ob/ob mice, 32 
which may be a mechanism of possible beneficial health effects of APCs in disturbed 33 
glucose metabolism.  34 
 35 
Keywords: apple procyanidins, insulin resistance, inflammation, ob/ob mouse 36 
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■INTRODUCTION  38 
  Insulin resistance induced by obesity readily develops into type 2 diabetes and leads 39 
to elevated risk of cardiovascular disease. The pathogenesis of type 2 diabetes is 40 
characterized by two major features, insulin resistance and impaired insulin secretion. 41 
If insulin demand due to insulin resistance is over the capacity of pancreatic β-cells, 42 
blood glucose homeostasis cannot be maintained, leading to chronic hyperglycemia. 43 
Reducing insulin resistance is therefore clinically important for the prevention and 44 
management of type 2 diabetes. 45 
The mechanism of insulin resistance is still unclear. Insulin resistance is reported to 46 
be associated with a state of chronic and low-grade inflammation in insulin target 47 
tissues including adipose tissue, liver and skeletal muscle. Tumor necrosis factor-α 48 
(TNF-α), a pro-inflammatory cytokine produced from accumulated fat, activates 49 
various signaling cascades, including c-Jun N-terminal kinase (JNK). JNK leads to 50 
serine phosphorylation of insulin receptor substrate (IRS)-1 and 2, and consequently 51 
induces insulin resistance.
1 




Epidemiological studies suggest that consumption of fruits and vegetables reduces 54 
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the risk of developing type 2 diabetes.
3,4
 The benefits of fruits and vegetables have 55 
been attributed to their dietary fiber and various phytochemicals, such as polyphenol. 56 
Apple is one of the most commonly consumed fruits in the world. Apple polyphenols 57 





 and anti-tumor activity.
7
 59 
Apple procyanidins (APCs) are the main ingredient of apple polyphenols 
8
 and 60 
consist of flavanol units such as (+)-catechin and (–)-epicatechin, which are linked 61 
together through 4→8 and 4→6 interflavonoid bonds, and have many isomeric forms 62 
depending on the extent of polymerization and the nature of their constituent units 63 
(Figure S1). Recent research has indicated that APCs have various beneficial effects on 64 
health, including anti-aging effects in Caenorhabditis elegans,
9
 an inhibitory effect on 65 
triglyceride absorption through inhibition of pancreatic lipase activity in mouse and 66 
human,
10
 and anti-inflammatory and immunomodulatory effects on intestinal epithelial 67 
cells.
11
  68 
However, there are few reports regarding ingestion of APCs and risk of type 2 69 
diabetes. In this study, we investigated the effects of APCs on glucose metabolism 70 
using model mice for obesity and type 2 diabetes. Our findings may lead to a strategy 71 
for development of therapeutic agents for impaired glucose tolerance and type 2 72 
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■MATERIALS AND METHODS 75 
Preparation of apple polyphenol extracts 76 
The procyanidin fraction was prepared from apple (Malus pumila cv. Fuji) by 77 
preparative column chromatography with the method of previous study.
12
 Briefly, the 78 
apple polyphenol fraction was prepared from apple juice using the preparative column 79 
with aromatic synthetic adsorbents, Sepabeads SP-850 (Mitsubishi Kasei Co., Ltd., 80 
Japan). Apple polyphenol extracts were lyophilized, and the powder obtained was 81 
dissolved in distilled water and adjusted to pH 6.5 with 5N NaOH. The sample was 82 
applied to a Diaion HP-20ss (Mitsubishi Kasei Co., Ltd., Japan) column, and after 83 
rinsing the column with distilled water, the procyanidin fraction was eluted with 25% 84 
ethanol. Finally, the eluate was concentrated by rotary evaporation at 45°C and 85 
lyophilized as the APCs fraction. APCs were analyzed using by reversed-phase HPLC 86 
equipped with an LC-10AD VP pump (Shimadzu, Kyoto, Japan), an SIL-10AD VP 87 
autosampler (Shimadzu), and a Inertsil ODS-3 (GL Sciences Inc., Tokyo, Japan) 88 
reversed-phase column (150ｘ4.6 mm i.d.) at 40°C. Mixtures of 10 mM KH2PO4 89 
solution (adjusted to pH 1.8 with H3PO4) and methanol was used as the mobile phase 90 
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[mobile phase A, 10 mM KH2PO4:MeOH (8:2) and mobile phase B, 10 mM 91 
KH2PO4:MeOH (5:5)] were used as the mobile phases with a flow rate of 1.0 ml/min. 92 
Detection was performed using a SPD-10A VP UV-vis detector (Shimadzu) at 280 nm. 93 
For the first 10 min, the initial eluent used was 0% mobile phase B, followed by a 94 
linear gradient from 100% mobile phase B for 40 min; subsequently the concentration 95 
was held at 100% mobile phase B for 15 min and then returned to the initial conditions. 96 
This fraction did not include phloretin glucoside (phlorizin) or chlorogenic acid 97 
(Figure 1). The former has a blood glucose lowering effect by inhibiting sodium 98 
glucose cotransporter (SGLT1 and SGLT2),13 and the latter has several beneficial 99 





5-week-old male B6.Cg-Lepob/J mice (C57BL/6J background) were purchased 103 
from Charles River Japan Inc. (Kanagawa, Japan). The phenotype is obese and insulin 104 
resistance but hyperglycemia is not so severe. They were divided into two groups: an 105 
APCs-treated and an untreated group. The mice were housed in individual under 106 
controlled environment at 23℃ and 12-hour light/dark cycle with free access to water 107 
and a commercial nonpurified diet (MF, Oriental Yeast Co., Tokyo, Japan). All animal 108 
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experiments were approved by the Kyoto University Animal Care Committee. 109 
Beginning at 8 weeks of age, mice were administered APCs dissolved in drinking 110 
water (0.5%, w/v) ad libitum for 4 weeks. Body weight and food intake were measured 111 
once every week and water intake was measured every day. During continuation of the 112 
APCs administration to 16 weeks of age, insulin tolerance test (ITT), oral glucose 113 
tolerance test (OGTT), and pyruvate tolerance test (PTT) were performed. 114 
 115 
Measurement of energy expenditure 116 
 Energy expenditure of the mice at the age of 16 weeks was measured for 48 hours 117 
using indirect calorimetry. Oxygen consumption and CO2 production were determined 118 
every 5 min in an open chamber with the mass spectrometry-based O2 and 119 
CO2 analyzer ARCO-2000 (ARCO system, Chiba, Japan). Oxygen consumption was 120 
normalized by lean body mass. 121 
 122 
Measurement of blood glucose, oral glucose tolerance test and insulin tolerance 123 
test 124 
After 4 weeks administration of water with or without 0.5% APCs, APCs-treated 125 
and untreated ob/ob mice were fasted overnight for 16 h, and received an oral dose of 126 
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1 g/kg glucose. Blood glucose levels and serum insulin concentrations were measured 127 
at 0, 15, 30, 60, and 120 min after oral injection by the glucose oxidase method (Sanwa 128 
Kagaku Kenkyusho, Nagoya, Japan) and an ELISA kit (Shibayagi Co. Ltd, Gunma, 129 
Japan), respectively. After 5 weeks administration of APCs, APCs-treated and 130 
untreated ob/ob mice were fasted for 16 h, and regular insulin (2 units/kg) was injected 131 
intraperitoneally. Blood glucose levels were measured at 0, 15, 30, 45, 60, 90, and 120 132 
min after injection.  133 
 134 
Pyruvate tolerance test 135 
Pyruvate was dissolved with 0.9% (wt/vol) sterile saline. APCs-treated and 136 
untreated ob/ob mice were fasted overnight for 16 h, and pyruvate (1 g/kg) was 137 
injected intraperitoneally. Blood glucose levels were measured at 0, 15, 30, 60, 90, and 138 




Calculation of homeostasis model assessment of insulin resistance 141 
The homeostasis model assessment of insulin resistance (HOMA-IR) was calculated 142 
using fasting blood glucose and insulin concentrations based on OGTT data. 143 
HOMA-IR is used to estimate insulin resistance in human and animals.
17,18
 HOMA-IR 144 
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was calculated using the following formula:
19
  145 
HOMA-IR = insulin (mU/L) x [glucose (mg/dL)/405]  146 
 147 
Measurement of body fat composition 148 
Body fat mass was measured by CT scan (LaTheta LCT-100, Aloka, Tokyo, Japan). 149 
The mice were anesthetized, and the images were analyzed using LaTheta software, 150 
version 1.00 and values of subcutaneous and visceral fat mass were quantified in grams 151 
(g). 152 
 153 
Measurement of serum adiponectin 154 
Mice at the age of 16 weeks were sacrificed and blood samples were taken. Serum 155 
adiponectin concentration was measured by ELISA kit (Otsuka Pharmaceutical Co. ltd, 156 
Tokyo, Japan) according to the instruction manuals. 157 
 158 
Histomorphology and immunohistochemistry 159 
The sections of paraffin embedding pancreas in mice at the age of 16 weeks were 160 
incubated with anti-glucagon mouse monoclonal antibody (cloneK79bB10, 1:2000 161 
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dilution; Abcam plc, Cambridge, UK) and polyclonal rabbit anti-insulin (H-86) 162 
antibody (1:100 dilution; Santa Cruz Biotechnology, Inc., Texas, U.S.A.). The sections 163 
were then incubated with goat anti-mouse IgG and goat anti-rabbit 164 
fluorescein-conjugated secondary antibody (1:200 dilution, Alexa Fluor 488; Alexa 165 
Fluor 546; Invitrogen/Life Technologies Japan, Tokyo, Japan). Two slides randomly 166 
selected from each pancreas were analyzed. After immunostaining, quantification of 167 
β-cell area was performed by immunofluorescent microscope using BZ-Ⅱ Analyzer 168 
software (Keyence Corp., Osaka, Japan). Results are expressed as percentage of total 169 
surveyed area containing cells positive for insulin. The insulin-positive cells were 170 
counted as the number of islets per area of pancreas.
20, 21
 171 
  Sections of liver tissues of mice at the age of 16 weeks were stained with Oil Red O 172 
and Hematoxylin and Eosin (H&E). For immunohistochemistry, the liver sections were 173 
incubated with anti-F4/80 rat-monoclonal antibody (1:100 dilution; Abcam plc, 174 
Cambridge, UK). The sections were then treated with anti-rat fluorescein-conjugated 175 
secondary antibody (Alexa Fluor 546; Invitrogen/Life Technologies Japan, Tokyo, 176 
Japan) and anti-rat horseradish peroxidase (HRP)-conjugated antibody (polyclonal 177 
rabbit anti-rat immunoglobulins/HRP; DakoCytomation, Glostrup, Denmark).
22
     178 
 179 
Page 10 of 40
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
11 
 
Measurement of total cholesterol and lipid contents in liver 180 
Hepatic lipids were extracted as described previously.
23
 Total cholesterol and 181 
triglyceride were measured at Skylight Biotech, Inc. (Akita, Japan) using cholesterol 182 
and triglyceride assay kits (choletest-CHO and choletest-TG, Sekisui Medical Co., Ltd., 183 
Tokyo, Japan). Hepatic lipid content was defined as weight per gram of liver tissue. 184 
 185 
Immunoblotting 186 
Liver isolated from APCs-treated and untreated ob/ob mice were lysed in ice-cold 187 
lysis buffer (10 mmol/l Tris [pH 7.2], 100 mmol/l NaCl, 1 mmol/l EDTA, 1% Nonidet 188 
P-40, and 0.5% sodium deoxycholate) containing protease inhibitor cocktail 189 
(Complete; Roche, Mannheim, Germany), phosphatase inhibitor cocktail (Calbiochem, 190 
Darmstadt, Germany), and 5 mmol/l sodium pyrophosphate. Immunoblotting was 191 
performed. Primary antibodies used were rabbit anti-phospho-Akt (Ser473) and 192 
anti-Akt from Cell Signaling (Danvers, MA); mouse anti-phospho-JNK and anti-JNK 193 
were from Sigma (St. Louis, MO). Secondary antibodies used were horseradish 194 
peroxidase-conjugated anti-rabbit and mouse antibody (GE Healthcare). Band 195 
intensities were quantified with Multi Gauge software (Fujifilm, Tokyo, Japan). 196 
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Isolation of total RNA and quantitative RT-PCR 198 
Total RNA was isolated from liver of APCs-treated mouse using Trizol (Invitrogen). 199 
SYBR Green PCR Master Mix (Applied Biosystems, Foster, CA, USA) was prepared 200 
for the quantitative RT-PCR run using TNF-α primer with the following sequence: 201 
5’-AAATGGGCTTTCCGAATTCA-3’ and 5’-CAGGGAAGAATCTGGAAAGGT-3’, 202 
IL-6 primer with the following sequence: 5’-GGAGGCTTAATTACACATGTT-3’ 203 
and 5’-TGATTTCAAGATGAATTGGAT-3’, IL-1β primer with the following 204 
sequence: 5’-ATCTTTGGGGTCCGTCAACTGAPDH-3’ and 205 
5’-GCAACTGTTCCTGAACTCAACT-3’. GAPDH mRNA was used as an internal 206 
control. The sequences of GAPDH primer are as follows: 207 
5’-AAATGGTGAAGGTCGG-3’ and 5’-TCGTTGATGGCAACAA-3’. The thermal 208 
cycling conditions were denaturation at 95 °C for 10 min followed by 50 cycles at 209 
95 °C for 15 s and 60 °C for 1 min. mRNA levels were measured by real-time 210 
quantitative RT-PCR using ABI PRISM 7000 Sequence Detection System (Applied 211 
Biosystems/Life Technologies Japan, Tokyo, Japan). 212 
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Statistical analysis 214 
The data are expressed as means ± SE. Statistical significance was determined by 215 
unpaired Student’s t-test. P < 0.05 was considered significant. 216 
 217 
■RESULTS 218 
Body weight, food intake, and energy expenditure 219 
  We first evaluated the effect of APCs on body weight of ob/ob mice. There was no 220 
difference between APCs-treated and untreated mice during the test period (Figure 2A). 221 
Dietary food intake (Figure 2B) and water intake (APCs-treated mice: 6.24 ± 0.32 ml 222 
of 0.5% APCs water per day, untreated mice: 7.11 ± 0.24 ml of water per day) were 223 
also unchanged. Similarly, energy expenditure was not significantly different between 224 
APCs-treated and untreated mice (Figure 2C).  225 
 226 
Glucose tolerance test and insulin tolerance test 227 
  In OGTT, blood glucose levels were significantly lower at 15 min and 30 min in 228 
APCs-treated ob/ob than those in untreated mice (Fig. 3A). The serum insulin levels 229 
did not differ at these time points (Figure 3B). The value of HOMA-IR was 230 
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significantly lower in APCs-treated (27.3 ± 7.9) than that in untreated mice (76.0 ± 231 
13.3). In ITT, blood glucose levels were significantly lower in APCs-treated ob/ob 232 
(Figure 3C). These data suggest that APCs ameliorate insulin resistance in ob/ob mice. 233 
Insulin resistance contributes to an adaptive change in pancreatic β-cell mass.24 We 234 
therefore observed pancreatic islets morphologically by immunohistochemistry using 235 
anti-insulin and anti-glucagon antibodies (Figure 3D). β-cell area was decreased by 236 
21 % in APCs-treated compared with that in untreated mice (Figure 3E). On the other 237 
hand, there was no difference in the number of islets (Figure 3F). These data suggest 238 
that hypertrophy of pancreatic islets was suppressed by treatment of APCs.  239 
 240 
Effects of APCs on body composition, adipocyte size, and serum adiponectin level 241 
We then examined the effects of APCs on adipose tissue, a target organ for insulin. 242 
There was no difference in lean mass and fat composition between APCs-treated and 243 
untreated mice (Figure 4A). In addition, the size of adipocytes and serum adiponectin 244 
levels did not change (Figure 4B and C). It is therefore unlikely that APCs have an 245 
effect on insulin resistance in adipose tissue. 246 
 247 
Effects of APCs on hepatic insulin signals and lipid content 248 
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  Hepatic gluconeogenesis is enhanced in the state of insulin resistance.25 In PTT, 249 
APCs-treated ob/ob mice displayed lower blood glucose levels at 15 min and 30 min 250 
after pyruvate injection, indicating that APCs treatment suppresses hepatic 251 
gluconeogenesis (Figure 5A). It was reported that Akt phosphorylation of ob/ob mice 252 
was down-regulated, indicating impairment of the insulin signaling.
26
 253 
Insulin-stimulated Akt phosphorylation was elevated in APCs-treated compared with 254 
untreated mice (Figure 5B). Accumulation of fat in liver induces insulin resistance.
27
 255 
We therefore estimated lipid content in liver. Interestingly, total cholesterol and TG 256 
contents in liver did not differ between APCs-treated and untreated mice (Figure 5C 257 
and D). Similarly, change of lipid content was not observed by using other methods 258 
such as H&E staining and Oil Red O staining (Figure 5E). These data indicate that 259 
APCs suppress hepatic gluconeogenesis by improving the insulin signal without 260 
altering fat accumulation in liver. 261 
 262 
Effects of APCs on inflammation in liver  263 
We then considered whether APCs influence inflammation in liver to ameliorate 264 
insulin resistance, and evaluated macrophage infiltration into liver by immunostaining 265 
using anti-F4/80 anti-body, a marker for mature mouse macrophage.
28
 The number of 266 
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macrophage in liver was decreased in APCs-treated ob/ob mice (Figure 6A). We 267 
examined the mRNA expression levels of pro-inflammatory cytokine in liver, and 268 
found that mRNAs of TNF-α and IL-6 were down-regulated by APCs treatment 269 
(Figure 6B). TNF-α activates TNF receptors on hepatocytes to induce JNK 270 
activation.
29
 We therefore examined JNK activation by immunoblotting using 271 
anti-phospho-JNK and anti-JNK antibody. Phosphorylation of JNK was decreased by 272 
APCs treatment in liver (Figure 6C). These data suggest that APCs treatment attenuates 273 
inflammation in liver. 274 
 275 
■DISSCUSSION 276 
  In this study, we show that oral administration of APCs ameliorates glucose 277 
intolerance in obese diabetic ob/ob mice.  278 
Continuous but not single (Figure S2) oral administration of APCs ameliorated glucose 279 
intolerance, and suppressed the expression of inflammation-related genes and 280 
phosphorylation of JNK in liver, suggesting that APCs improve insulin sensitivity in 281 
liver through suppression of chronic inflammation. In our preliminary experiments, it 282 
was confirmed that the dosage of 0.5% APCs in drinking water is the appropriate 283 
concentration that has no effects on water intake, food intake or body weight. 284 
 Obesity is associated with chronic, low-grade, and systemic inflammation that may 285 
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contribute to the development of insulin resistance and type 2 diabetes.
30
 Generally, 286 
adipose tissue inflammation is considered to initiate adipocyte hypertrophy and 287 
hyperplasia and to influence release of adipocytokines and pro-inflammatory signaling. 288 
On the other hand, obesity also is associated with the regulation of adipocytokine 289 
secretion, and causes adverse effects on inflammation and insulin sensitivity.31 290 





 There are several reports suggesting that 292 
procyanidins improve glycemic control.
33
 In accord with these data, while the body 293 
weight, food intake, and fat mass of APCs-treated ob/ob mice were unchanged 294 
compared with those of untreated mice, the insulin sensitivity was significantly 295 
improved in our study. 296 
  The beneficial effects of procyanidins from various plants have been investigated. 297 
Procyanidin from cinnamon was reported to lower levels of blood glucose, total 298 
cholesterol, low-density cholesterol, and hemoglobin A1c in type 2 diabetes.
33 
299 
Persimmon peel proanthocyanidins decrease blood glucose levels and glycosylated 300 
protein concentrations and have a protective effect against diabetes-induced oxidative 301 
stress in streptozotocin-induced diabetic rats.
34
 Recently, tetrameric procyanidins from 302 
cacao liquor were shown to increase the levels of plasma glucagon-like peptide-1 303 
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(GLP-1), an incretin hormone that potentiates insulin secretion.
35
 Our data showing 304 
that APCs ameliorate impaired hepatic insulin signaling in ob/ob mice may be useful in 305 
clarifying the therapeutical actions of substances from vegetables and fruits. 306 
    Hepatic insulin resistance is a key feature of obesity-related type 2 diabetes.
36
 307 
Kupffer cells, which are liver-resident macrophage-like cells, are activated by 308 
inflammation, apoptosis, and necrosis of hepatocytes. Activation of Kupffer cells 309 
causes the release of inflammatory cytokines such as TNF-α and IL-6 in liver.
37
 It is 310 
reported that accumulation of fat in hepatocyte induces inflammation in liver.
38
 311 
However, APCs treatment decreased the number of macrophages and the expression 312 
levels of TNF-α and IL-6 in liver without changing the lipid content in the liver of 313 
ob/ob mice. These data suggest that the effect of APCs on liver inflammation is not due 314 
to suppression of fat accumulation in hepatocytes. 315 
    It was suggested that intestinal bacteria may contribute to the pathogenesis of 316 
inflammation in liver. Lipopolysaccharide (LPS), one of the gut-derived endotoxins, 317 
was reported to cause liver damage via activation of Kupffer cells and release of 318 
TNF-α and other cytokines.
39
 Obesity alters the ecology of intestinal microbiota.
40
 It is 319 
reported that ob/ob mice have higher endotoxin levels in the portal blood than that in 320 
wild-type mice.
41
 Recent studies suggested that procyanidins can be degraded by some 321 
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kinds of intestinal microbiota
42
 and also that administration of apple flavonoid alters 322 
intestinal microbiota.
43
 In addition to our preliminary experiment using ob/ob mouse 323 
(data not shown), we have carried out an experiment whether APCs could change the 324 
microbiota of high-fat/high-sucrose (HFHS)-fed C57BL/6J male mice.
44
 We found the 325 
chronic oral administration of high polymeric APCs prevent obesity associated with 326 
gut microbial and metabolic changes. It is therefore possible that APCs suppress 327 
inflammation in liver not by decreasing fat accumulation but through effects on 328 
intestinal microbiota. Glycolysis, gluconeogenesis, glycogenolysis and glycogen 329 
synthesis is involved in the maintenance of blood glucose levels.
45
 Both 330 
gluconeogenesis and glycogenolysis are important in glucose production in liver. 331 
Pyruvate is one of well-known substances of gluconeogenesis. In this study, we 332 
showed APCs are considered to be suppress pyruvate induced gluconeogenesis (Figure 333 
5A). However, the effect of APCs on glycogen metabolism is not clear. Further studies 334 
are needed to clarified the details of how APCs ameliorate glucose resistance in 335 
diabetic state. 336 
  In conclusion, our data indicate that oral administration of APCs ameliorates insulin 337 
resistance by improving hepatic insulin signaling through suppression of inflammation 338 
in ob/ob mice. Moreover, further investigation of the mechanism of the effects of APCs 339 
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on glucose metabolism could shed light on the pathophysiology of insulin resistance 340 
and suggest new targets for type 2 diabetes therapy. 341 
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JNK (c-Jun N-teminal kinase), IRS (insulin receptor substrate), SGLT (sodium glucose 




(1)  Rudich, A.; Tirosh, A.; Potashnik, R.; Hemi, R.; Kanety, H.; Bashan, N. Prolonged 
oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. 
Page 21 of 40
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
22 
 
Diabetes 1998, 47, 1562-1569. 
(2) Tiganis, T. Reactive oxygen species and insulin resistance: the good, the bad and the 
ugly. Trends in Pharmacol. Sci. 2011, 32, 82-89. 
(3) Hung, H. C.; Joshipura, K. J.; Jiang, R.; Hu, F. B.; Hunter, D.; Smith-Warner, S. A.; 
Colditz, G. A.; Rosner, B.; Spiegelman, D.; Willett, W. C. Fruit and vegetable intake 
and risk of major chronic disease. J. Natl. Cancer Institute. 2004, 96, 1577-1584. 
(4) Muraki, I.; Imamura, F.; Manson, J. E.; Hu, F. B.; Willett, W. C.; van Dam; R. M.; 
Sun, Q. Fruit consumption and risk of type 2 diabetes: results from three prospective 
longitudinal cohort studies. BMJ 2013, 347, f5001. 
(5) Leontowicz, H.; Gorinstein, S.; Lojek, A.; Leontowicz, M.; Ci, z, M.; Soliva-Fortuny, 
R.; Park, Y. S.; Jung, S. T.; Trakhtenberg, S.; Martin-Belloso, O. Comparative content 
of some bioactive compounds in apples, peaches and pears and their influence on 
lipids and antioxidant capacity in rats. J. Nutr. Biochem. 2002, 13, 603-610. 
(6) Jung, M.; Triebel, S.; Anke, T.; Richling, E.; Erkel, G. Influence of apple 
polyphenols on inflammatory gene expression. Mol. Nutr. Food Res. 2009. 53, 
1263-1280. 
(7) Lapidot, T.; Walker, M. D.; Kanner, J. Can apple antioxidants inhibit tumor cell 
proliferation? Generation of H(2)O(2) during interaction of phenolic compounds with 
Page 22 of 40
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
23 
 
cell culture media. J. Agric. Food Chem. 2002, 50, 3156-3160. 
(8) Shoji, T.; Mutsuga, M.; Nakamura, T.; Kanda, T.; Akiyama, H.; Goda, Y. Isolation 
and structural elucidation of some procyanidins from apple by low-temperature 
nuclear magnetic resonance. J. Agric. Food Chem. 2003, 51, 3806-3813. 
(9) Vayndorf, E. M.; Lee, S. S.; Liu, R. H. Whole apple extracts increase lifespan, 
healthspan and resistance to stress in Caenorhabditis elegans. J. Funct. Foods, 2013, 
5, 1236-1243. 
(10) Sugiyama, H.; Akazome, Y.; Shoji, T.; Yamaguchi, A.; Yasue, M.; Kanda, T.; 
Ohtake, Y. Oligomeric procyanidins in apple polyphenol are main active 
components for inhibition of pancreatic lipase and triglyceride absorption. J. Agric. 
Food Chem. 2007, 55, 4604-4609. 
(11) Yoshioka, Y.; Akiyama, H.; Nakano, M.; Shoji, T.; Kanda, T.; Ohtake, Y.; Takita, 
T.; Matsuda, R.; Maitani, T. Orally administered apple procyanidins protect against 
experimental inflammatory bowel disease in mice. Int. Immunopharmacol. 2008, 8, 
1802-1807. 
(12) Yanagida, A.; Kanda, T.; Takahashi, T.; Kamimura, A.; Hamazono, T.; Honda, S. 
Fractionation of apple procyanidins according to their degree of polymerization by 
normal-phase high-performance liquid chromatography. J. Chromatogr. A. 2000, 890, 
Page 23 of 40
ACS Paragon Plus Environment




(13) Kahn, B. B.; Shulman, G. I.; DeFronzo, R. A.; Cushman, S. W.; Rossetti, L. 
Normalization of blood glucose in diabetic rats with phlorizin treatment reverses 
insulin-resistant glucose transport in adipose cells without restoring glucose 
transporter gene expression. J. Clin.Invest. 1991, 87, 561-570. 
(14) Bagdas, D.; Etoz, B. C.; Gul, Z.; Ziyanok, S.; Inan, S.; Turacozen, O.; Gul, N. Y.; 
Topal, A.; Cinkilic, N.; Tas, S.; Ozyigit, M. O.; Gurun, M. S. In vivo systemic 
chlorogenic acid therapy under diabetic conditions: Wound healing effects and 
cytotoxicity/genotoxicity profile. Food Chem. Toxicol. 2015, 81, 54-61. 
(15) Onakpoya, I. J.; Spencer, E. A.; Thompson, M. J.; Heneghan, C. J. The effect of 
chlorogenic acid on blood pressure: a systematic review and meta-analysis of 
randomized clinical trials. J. Hum. Hypertens. 2015, 29, 77-81. 
(16) Robertson, K.; Lu, Y.; De Jesus, K.; Li, B.; Su, Q.; Lund, PK.; Liu, JL. A 
general and islet cell-enriched overexpression of IGF-I results in normal islet cell 
growth, hypoglycemia, and significant resistance to experimental diabetes. Am J 
Physiol Endocrinol Metab. 2008, 294, E928-38. 
(17) Konrad, D.; Rudich, A.; Schoenle, E. J. Improved glucose tolerance in mice 
receiving intraperitoneal transplantation of normal fat tissue. Diabetologia 2007, 50, 
Page 24 of 40
ACS Paragon Plus Environment




(18) Matthews, D. R.; Hosker, J. P.; Rudenski, A. S.; Naylor, B. A.; Treacher, D. F.; 
Turner, R. C. Homeostasis model assessment: insulin resistance and beta-cell 
function from fasting plasma glucose and insulin concentrations in man. Diabetologia 
1985, 28, 412-419. 
(19) Mlinar, B.; Marc, J.; Janez, A.; Pfeifer, M. Molecular mechanisms of insulin 
resistance and associated diseases. Clin. Chim. Acta. 2007, 375, 20-35. 
(20) Fløyel, T.; Brorsson, C.; Nielsen, LB.; Miani, M.; Bang-Berthelsen, CH.; 
Friedrichsen, M.; Overgaard, AJ.; Berchtold, LA.; Wiberg, A.; Poulsen, P.; Hansen, 
L.; Rosinger, S.; Boehm, BO.; Ram, R.; Nguyen, Q.; Mehta, M.; Morahan, G.; 
Concannon, P.; Bergholdt, R.; Nielsen, JH.; Reinheckel, T.; von Herrath, M.; Vaag, 
A.; Eizirik, DL.; Mortensen, HB.; Størling, J.; Pociot, F. 
CTSH regulates β-cell function and disease progression in newly diagnosed type 1 
diabetes patients. Proc Natl Acad Sci U S A. 2014, 111, 10305-10310. 
(21) Nasteska, D.; Harada, N.; Suzuki, K.; Yamane, S.; Hamasaki, A.; Joo, E.; 
Iwasaki, K.; Shibue, K.; Harada, T.; Inagaki, N. Chronic reduction of GIP secretion 
alleviates obesity and insulin resistance under high-fat diet conditions. Diabetes. 
2014, 63, 2332-2343. 
Page 25 of 40
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
26 
 
(22) Kuroda, N.; Inoue, K.; Ikeda, T.; Hara, Y.; Wake, K.; Sato, T. 
Apoptotic response through a high mobility box 1 protein-dependent mechanism in 
LPS/GalN-induced mouse liver failure and glycyrrhizin-mediated inhibition. PLoS 
One 2014, 9, e92884. 
(23) Folch, J.; Lees, M.; Sloane Stanley, G. H. A simple method for the isolation and 
purification of total lipides from animal tissues. J. Biol.Chem. 1957, 226, 497-509. 
(24) Mezza, T.; Muscogiuri, G.; Sorice, G. P.; Clemente, G.; Hu, J.; Pontecorvi, A.; 
Holst, J. J.; Giaccari, A.; Kulkarni, R. N. Insulin resistance alters islet morphology 
in nondiabetic humans. Diabetes 2014, 63, 994-1007. 
(25) Wahren, J.; Ekberg, K. Splanchnic regulation of glucose production. Annu. Rev. 
Nutr. 2007, 27, 329-345. 
(26) Standaert, M. L.; Sajan, M. P.; Miura, A.; Kanoh, Y.; Chen, H. C.; Farese, R. V.; 
Jr., Farese, R. V. Insulin-induced activation of atypical protein kinase C, but not 
protein kinase B, is maintained in diabetic (ob/ob and Goto-Kakazaki) liver. 
Contrasting insulin signaling patterns in liver versus muscle define phenotypes of 
type 2 diabetic and high fat-induced insulin-resistant states. J. Biol.Chem. 2004, 279, 
24929-24934. 
(27) Samuel, V. T.; Liu, Z. X.; Qu, X.; Elder, B. D.; Bilz, S.; Befroy, D.; Romanelli, A. 
Page 26 of 40
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
27 
 
J.; Shulman, G. I. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver 
disease. J. Biol.Chem. 2004, 279, 32345-32353. 
(28) Baratta, J. L.; Ngo, A.; Lopez, B.; Kasabwalla, N.; Longmuir, K. J.; Robertson, 
R. T. Cellular organization of normal mouse liver: a histological, quantitative 
immunocytochemical, and fine structural analysis. Histochem. Cell Biol. 2009, 131, 
713-726. 
(29) Schwabe, R. F.; Brenner, D. A. Mechanisms of Liver Injury. I. 
TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. Am. J. 
Physiol. Gastroint. Liver Physiol. 2006, 290, G583-589. 
(30) Jimenez-Gomez, Y.; Mattison, J. A.; Pearson, K. J.; Martin-Montalvo, A.; 
Palacios, H. H.; Sossong, A. M.; Ward, T. M.; Younts, C. M.; Lewis, K.; Allard, J. 
S.; Longo, D. L.; Belman, J. P.; Malagon, M. M.; Navas, P.; Sanghvi, M.; Moaddel, 
R.; Tilmont, E. M.; Herbert, R. L.; Morrell, C. H.; Egan, J. M.; Baur, J. A.; Ferrucci, 
L.; Bogan, J. S.; Bernier, M.; de Cabo, R. Resveratrol improves adipose insulin 
signaling and reduces the inflammatory response in adipose tissue of rhesus 
monkeys on high-fat, high-sugar diet. Cell Metab. 2013, 18, 533-545. 
(31) de Luca, C.; Olefsky, J. M. Inflammation and insulin resistance. FEBS Lett. 2008, 
582, 97-105. 
Page 27 of 40
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
28 
 
(32) Akiyama, H.; Sato, Y.; Watanabe, T.; Nagaoka, M. H.; Yoshioka, Y.; Shoji, T.; 
Kanda, T.; Yamada, K.; Totsuka, M.; Teshima, R.; Sawada, J.; Goda, Y.; Maitani, T. 
Dietary unripe apple polyphenol inhibits the development of food allergies in murine 
models. FEBS Lett. 2005, 579, 4485-4491. 
(33) Qin, B.; Panickar, K. S.; Anderson, R. A. Cinnamon: potential role in the 
prevention of insulin resistance, metabolic syndrome, and type 2 diabetes. J. 
Diabetes Sci. Technol. 2010, 4, 685-693. 
(34) Lee, Y. A.; Kim, Y. J.; Cho, E. J.; Yokozawa, T. Ameliorative effects of 
proanthocyanidin on oxidative stress and inflammation in streptozotocin-induced 
diabetic rats. J. Agric. Food Chem. 2007, 55, 9395-9400. 
(35) Yamashita, Y.; Okabe, M.; Natsume, M.; Ashida, H. Cinnamtannin A2, a 
tetrameric procyanidin, increases GLP-1 and insulin secretion in mice. Biosci. 
Biotechnol. Biochem. 2013, 77, 888-891. 
(36) Perseghin, G. Viewpoints on the way to a consensus session: where does insulin 
resistance start? The liver. Diabetes Care 2009, 32 Suppl 2, S164-167. 
(37) Dixon, L. J.; Barnes, M.; Tang, H.; Pritchard, M. T.; Nagy, L. E. Kupffer cells in 
the liver. Comprehensive Physiol. 2013, 3, 785-797. 
(38) Michelotti, G. A.; Machado, M. V.; Diehl, A. M. NAFLD, NASH and liver 
Page 28 of 40
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
29 
 
cancer. Nat. Rev. Gastroenterol. Hepatol. 2013, 10, 656-665. 
(39) Luedde, T.; Schwabe, R. F. NF-kappaB in the liver--linking injury, fibrosis and 
hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol. 2011, 8, 108-118. 
(40) Ley, R. E.; Backhed, F.; Turnbaugh, P.; Lozupone, C. A.; Knight, R. D.; Gordon, 
J. I. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. U S A, 2005, 102, 
11070-11075. 
(41) Brun, P.; Castagliuolo, I.; Di Leo, V.; Buda, A.; Pinzani, M.; Palu, G.; Martines, 
D. Increased intestinal permeability in obese mice: new evidence in the pathogenesis 
of nonalcoholic steatohepatitis. Am. J. Physiol. Gastroint. Liver Physiol. 2007, 292, 
G518-525. 
(42) Ou, K.; Sarnoski, P.; Schneider, K. R.; Song, K.; Khoo, C.; Gu, L.. Microbial 
catabolism of procyanidins by human gut microbiota. Mol. Nutr. Food Res. 2014, 58, 
2196-2205. 
(43) Espley, R. V.; Butts, C. A.; Laing, W. A.; Martell, S.; Smith, H.; McGhie, T. K.; 
Zhang, J.; Paturi, G.; Hedderley, D.; Bovy, A.; Schouten, H. J.; Putterill, J.; Allan, A. 
C.; Hellens, R. P. Dietary flavonoids from modified apple reduce inflammation 
markers and modulate gut microbiota in mice. J. Nutr. 2014, 144, 146-154. 
(44) Masumoto, S.; Terao, A.; Yamamoto, Y.; Mukai, T.; Miura, T.; Shoji, T. 
Page 29 of 40
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
30 
 
Non-absorbable apple procyanidins prevent obesity associated with gut microbial 
and metabolomic changes. Sci Rep. 2016, 6: 31208. 
(45) Corssmit, EP.; Romijn, JA.; Sauerwein, HP. Regulation of glucose 
production with special attention to nonclassical regulatory mechanisms: a review. 




Reversed phase HPLC profile of apple polyphenol (upper) and apple procyanidins 
(lower). These panels show that our apple procyanidins do not include chlorogen acid or 
phloretin glucoside (Phlorizin) fractions, which are included as apple polyphenols. 
 
Figure 2 
Effects of APCs administration on body weight, food intake, and energy expenditure in 
ob/ob mice. (A) Body weight (n=12) and (B) food intake (n=12) were measured once 
every week.  (C) Energy expenditure (n=4) was measured for 48 h. APCs (-) and APCs 
(+) indicate APCs-untreated and APCs-treated ob/ob mice, respectively. Results are 
presented as mean ± SE. ＊P<0.05 
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Effects of APCs administration on OGTT, ITT, and pancreatic islet size in ob/ob mice.  
(A) Blood glucose levels and (B) serum insulin levels were measured during OGTT 
(load of glucose 1g/kg body weight). (C) Blood glucose levels measured during ITT 
(load of insulin 2U/kg body weight) (D) immunocytochemistry of pancreatic islets. (E) 
β-cell area in the total pancreatic area (n=4) and (F) the number of islets per area of 
pancreas (n=4). APCs (-) and APCs (+) indicate APCs-untreated and APCs-treated 
ob/ob mice, respectively. Results are presented as mean ± SE.＊P<0.05 
 
Figure 4 
Effects of APCs administration on adipose tissue adipocyte size and serum adiponectin 
level in ob/ob mice. (A) Visceral, subcutaneous, and total fat mass in APCs-treated and 
untreated mice were measured using CT images of transverse abdominal sections (n=4). 
(B) Representative images of HE staining of adipose tissue section. (C) Serum 
adiponectin concentrations (n=8). APCs (-) and APCs (+) indicate APCs-untreated and 
treated ob/ob mice, respectively. Results are presented as mean ± SE. 
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Effects of APCs administration on liver tissue in ob/ob mice. (A) Glucose levels 
measured during PTT (load of pyruvate 1g/kg body weight, n=8) (B) The ratio of 
phosphorylated Akt to total Akt (t-Akt) in liver tissues (n=3). (C) Total cholesterol 
(n=4) level and (D) triglycerides level in liver were measured (n=4). (E) HE and Oil red 
O staining of the liver. APCs (-) and APCs (+) indicate APCs-untreated and treated 
ob/ob mice, respectively. Results are presented as mean ± SE. ＊P<0.05 
 
Figure 6 
Effects of APCs administration on liver inflammation in ob/ob mice. 
(A) Immunohistochemistry with anti-F4/80 antibody in liver of APCs-treated and 
untreated mice. Arrows indicate representative macrophages in liver. (B) mRNA levels 
of TNF-α, IL-6, and IL-1β in the liver (n=8). (C) Effects of APCs administration on the 
ratio of phosphorylated JNK to total JNK (t-JNK) in liver in ob/ob mice (n=3). APCs (-) 
and APCs (+) indicate APCs-treated and untreated ob/ob mice, respectively. Results are 
presented as mean ± SE. 
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Ameliorate insulin resistance via suppression of pro-inflammatory cytokines expression in liver
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